After Hours
$
27.01
Change
+0.01 +0.04%
Volume
Volume 0
Apr 21, 2010, 5:08 p.m.
Real time quotes
Previous close
$ 27.01
$ 27.00
Change
-0.01 -0.04%
Day low
Day high
$26.99
$27.01
52 week low
52 week high
$7.38
$27.05
Market cap
$677.77M
Average volume
812,314
P/E ratio
N/A
EPS
N/A
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on FACT
-
1001511958
Abbott adjusted Q2 EPS $1.01
- John Ittner
-
1001511720
Abbott Q2 EPS steady at 83 cents
- John Ittner
-
1001511844
Abbott Q2 sales $8.8 bln vs $7.5 bln
- John Ittner
-
998137638
Abbott, Neurocrine agree to develop Elagolix
- Simon Kennedy
- Loading more headlines...
Where does this data come from?
Hulbert Interactive »
For more than 25 years, the Hulbert database has tracked the performance and recommendations of over 180 investment newsletters.
Analyst Estimates »
A data point based on hundreds of brokers buy, sell and hold rating.
Community (MarketWatch) »
Sentiment for this symbol comes from users like you, the MarketWatch community, on active picks. Make picks below to participate.
Sentiment on FACT
Where will FACT close from its current price?
Other News on FACT
-
1005490982
Arena Pharma: Using Options to Trade on FDA's Decision for Key Obesity Drug
- Seeking Alpha
- Loading more headlines...
Press Releases on FACT
-
1005904681
Abbott Receives FDA Approval for First Automated Molecular Test for Assessing Hepatitis B Treatment
- PR Newswire
-
1005899901
Equity Research on GlaxoSmithKline and Abbott Laboratories - The Emerging Markets Opportunities
- Marketwire
-
1002627364
USIBC Salutes Abbott Laboratories for 100 Years of Improving Healthcare in India
- BusinessWire
-
1001673885
Abbott to Present at Wedbush Securities Life Sciences Best Ideas MAC Conference
- PR Newswire
- Loading more headlines...
